IVIM Health vs MyStart: Compare GLP-1 Programs & Pricing
Side-by-side IVIM Health and MyStart: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
IVIM Health and MyStart are telehealth companies that help adults access prescription GLP‑1 therapies and related care through virtual visits. This comparison focuses on pricing, membership requirements, clinical oversight, and medication delivery so you can make an informed choice before booking an evaluation.
Visit IVIM Health
Explore MyStart
IVIM Health vs MyStart: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| IVIM Health | $99.00 | $149.00 | Free 1st Month Membership (Code: GIFT75) | $75.00 — Yes |
| MyStart | $179.00 | $299.00 | (Code: EXPLORE2026) | — |
Start with IVIM Health
Start with MyStart
IVIM Health vs MyStart: Pricing Comparison
IVIM Health lists semaglutide starting at $99.00 and tirzepatide from $149.00, making its entry prices lower than MyStart’s published starting points of $179.00 for semaglutide and $299.00 for tirzepatide. IVIM also advertises a free first month of membership with code GIFT75, while MyStart accepts code EXPLORE2026 for platform offers. Membership models vary and can affect total monthly cost.
When comparing cost, include the membership fee listed by IVIM Health ($75.00) when calculating ongoing pricing. MyStart’s public listing does not show a mandatory membership fee in the same way, so out‑of‑pocket medication and delivery costs may be the primary driver there. Always verify final pricing during checkout and ask about shipping and refill policies before enrolling.
IVIM Health vs MyStart: Medical Process & Accessibility
Both providers operate under U.S. telehealth rules and require an initial clinical assessment before any prescription is issued. Typical steps include an online intake, a licensed clinician review, and a prescription sent to a pharmacy. This evaluation is intended to assess medical history, current medications, and contraindications so a safe prescribing decision can be made.
Telehealth care for GLP‑1 therapies must follow clinical guidelines and state licensing requirements. Neither provider can legally prescribe without reviewing your health information. If you have a history of pancreatitis, certain thyroid conditions, or are pregnant or breastfeeding, discuss these with a clinician; such factors may influence safe prescribing decisions.
IVIM Health vs MyStart: Medication Quality & Safety
Both companies typically work with licensed U.S. pharmacies to fulfill prescriptions. Some services dispense branded pharmaceuticals when available; others use compounded alternatives. Compounded products differ from FDA‑approved branded formulations and should be prescribed only after a clinician determines they are appropriate for you.
Review MyStart Medication Options
IVIM Health vs MyStart: Customer Experience & Support
Customer reports suggest IVIM Health emphasizes affordability and faster onboarding, while MyStart prioritizes ongoing clinical communication and structured follow-up. Shipping times, refill processes, and patient messaging tools vary; consider which factors are most important for your care continuity.
Join IVIM Health
Get Started with MyStart
Final Verdict
Choose IVIM Health if your priority is lower starting prices and a clear membership structure. Choose MyStart if you prefer a platform that highlights care coordination and follow‑up. Both are licensed telehealth options that require clinician assessment prior to prescribing; neither replaces in‑person care when clinically necessary.
Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP‑1 and related medications are prescription drugs; a licensed clinician must evaluate you prior to prescribing. Medication availability, pricing, and promotions can change. Always consult a licensed healthcare professional before starting or changing treatment.